How iPS cells changed the world.
Megan
M
Scudellari
D000328:Adult; D000544:Alzheimer Disease / Q000235:genetics; D000818:Animals; D064113:CRISPR-Cas Systems / Q000235:genetics; D000067470:Cellular Reprogramming Techniques; D004353:Drug Evaluation, Preclinical; D005260:Female; D005818:Genetic Engineering; D005901:Glaucoma / Q000473:pathology / Q000628:therapy; D000066449:Human Embryonic Stem Cells / Q000166:cytology / Q000378:metabolism; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000276:immunology / Q000378:metabolism* / Q000637:transplantation; D008268:Macular Degeneration / Q000473:pathology / Q000628:therapy; D051379:Mice; D008831:Microcephaly / Q000473:pathology / Q000821:virology; D008954:Models, Biological; D058953:Neural Stem Cells / Q000473:pathology / Q000821:virology; D009940:Organoids / Q000166:cytology / Q000473:pathology / Q000821:virology; D010300:Parkinson Disease / Q000473:pathology / Q000628:therapy; D057285:Precision Medicine; D011786:Quality Control; D044968:Regenerative Medicine; D012106:Research; D013997:Time Factors; D000071244:Zika Virus / Q000472:pathogenicity